aod9604 stimulates adipocyte lipolysis AOD-9604 5mg – Neurovia Schematic illustration of the lipolysis

While research is still ongoing, several key advantages have been identified

Gradientdose 5-amino-1-methylquinolinium treatment further enables investigation of doseresponse relationships between NNMT inhibition, NAD+ levels, and metabolic efficiency, improving mechanistic understanding and supporting targetbased research for metabolic diseases

Consistent with a decrease in the rate of efflux of fatty acids, intracellular fatty acid levels have been found to be threefold higher in adipocytes from aFABP/ALBP/aP2 nulls compared with wild types (22)

While generally well-tolerated, some patients may experience side effects